SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-076250
Filing Date
2015-11-05
Accepted
2015-11-05 16:15:53
Documents
3
Period of Report
2015-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-22387_18k.htm 8-K 25375
2 EX-99.1 a15-22387_1ex99d1.htm EX-99.1 106773
3 GRAPHIC g223871mmi001.gif GRAPHIC 1481
  Complete submission text file 0001104659-15-076250.txt   135541
Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034
Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000
Vitae Pharmaceuticals, Inc (Filer) CIK: 0001157602 (see all company filings)

IRS No.: 043567753 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36617 | Film No.: 151200840
SIC: 2834 Pharmaceutical Preparations